Cell Culture Market

Cell Culture Market by Product (Consumables (Media, Serum, Reagent, Vessels), Equipment (Bioreactor, Centrifuge, Incubator)), Application (Vaccines, mAbs, Diagnostics, Tissue Engineering), End User (Pharma, Biotech, Hospital) - Global Forecast to 2026

Report Code: BT 2561 Feb, 2022, by marketsandmarkets.com

[490 Pages Report] The global cell culture market is projected to reach USD 41.3 billion by 2026 from USD 22.8 billion in 2021, at a CAGR of 12.6 % between 2021 and 2026. The growth of this market is majorly driven by the growing awareness about the benefits of cell-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, the launch of advanced cell culture products, and the growing focus on personalized medicine. On the other hand, the high cost of cell biology research is restraining the growth of this market.

Cell Culture Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the Cell Culture Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic. The COVID-19 pandemic has increased the burden on healthcare systems across the globe. According to the WHO, there were 271,963,258 confirmed cases of COVID-19, including 5,331,019 deaths (as of December 17, 2021). The highest number of deaths was in the Americas, followed by Europe and Southeast Asia.

The COVID-19 pandemic has prompted key pharmaceutical and biotechnology companies to produce a number of vaccines or antiviral drugs for COVID-19 have been approved or are under development and manufacturing. As cell culture is an integral part of drug development and manufacturing, this has increased the demand for cell culture products.

Cell culture-based viral vaccines are used globally to immunize humans against infections. Currently, mammalian cell lines are used to culture the SARS-CoV-2 virus for research purposes. In bioproduction, culture mediums provide nutrients and component cells required to grow under controlled environmental conditions to produce therapeutics with the desired level of pharmaceutical efficacy. Cell culture products such as cell culture media, reagents, and equipment help researchers investigate cellular behavior, which will help with vaccine development.

The use of cell culture technologies is expected to speed up vaccine research and development processes. The CSIR-Centre for Cellular and Molecular Biology (CCMB, India) has established stable cultures of SARS-CoV-2 from patients’ samples. The potential uses of cultured SARS-CoV-2 have been identified for vaccine production, antibodies or anti-dotes, testing of antibodies, and drug screening, among other activities.

Cell culture is a continuous process of developing substrates for the safe production of viral vaccines. However, increasing global demand and strict safety rules for novel vaccines to control and eradicate the coronavirus's spread has forced researchers and manufacturers toward the development of cell culture-based vaccines. This development significantly increased the demand for cell culture products during 2020 and 2021.

Global Cell Culture Market Dynamics

DRIVER: Growing awareness about the benefits of cell-based vaccines

The growth in population, climate change, and increasing contact between humans and animals have increased the threat of new virus outbreaks. Influenza and COVID-19, for example, have proven unpredictable and recurring events that pose a significant economic and social burden. As of February 4, 2022, 386.55 million cases of COVID-19 were confirmed globally, including 5.71 million deaths, by the WHO. The increasing incidence of infectious diseases and the growing risk of pandemics are expected to drive vaccine demand worldwide. In the pharmaceutical industry, cell culture has become a prominent part of vaccine production. The cell culture technology has been used to produce vaccines for rotavirus, polio, smallpox, hepatitis, rubella, and chickenpox. Cell-based flu vaccines have also been approved for use in the US and many European countries. Increasing awareness of the benefits of cell culture-based vaccines, coupled with the regulatory approval of several cell culture-based vaccines worldwide, are the major factors that are expected to support the growth of the cell culture market during the forecast period.

RESTRAINT: High cost of cell biology research

Cell biology involves extensive R&D on new therapies such as stem cell and gene therapies. The equipment, reagents, and other products associated with research must be of the highest quality to provide accurate results. Owing to the growing need to maintain high-quality standards (through the use of high-grade products) and comply with guidelines set up by regulatory bodies, the cost of cell biology research has increased considerably. As a result, various academic institutes and small-scale companies with limited budgets cannot afford to conduct cell biology research. Since microcarriers find applications in stem cell biology, this factor is likely to be a hindrance to market growth. Additionally, since microcarriers adhere to cells, the cells need to be harvested, which further increases downstream processing costs. This, in turn, is likely to restrain the growth of the cell culture market.

OPPORTUNITY: Growing demand for 3D cell culture

3D cell cultures are gaining demand over 2D cell cultures due to multiple reasons. 2D cell culture methods involve growing cells on flat surfaces as 2D monolayers. However, these cells adhere only to cell culture vessels and attach only to cells at the periphery; this limits multi-dimensional cell cultures. Researchers have come up with 3D cell cultures to resolve these issues. These cultures have proven to be efficient in several studies of basic biological mechanisms, such as cell number monitoring, cell viability, cell proliferation, and cell morphology. Moreover, 3D cell cultures have greater stability and longer lifespans as compared to 2D cultures. The benefits of 3D cell cultures have attracted several players to invest in this field. In June 2020, Lonza and CELLINK collaborated to offer a 3D bioprinting solution designed to advance complete 3D cell culture workflows. In October 2019, Corning Incorporated added two new 3D culture products, including a 3D cell culture microplate and a matrix for organoid culture, to its cell culture product portfolio. Also, there has been a rise in focus on products like microfluidic organ-on-a-chip models, which are 3D microfluidic cell culture chips engineered to mimic the physiology of an organ. 3D cells are grown in scaffolds within the chambers of a microchip. Various startups in the 3D cell culture space are receiving funding from venture capitalists to accelerate the marketing and distribution of 3D cell culture products. For example, in May 2019, Kiyatec Inc. (US) received USD 3 million in Series 2 funding for developing ex vivo 3D culture technology to model and detect cancer patients’ response to drug therapies. In May 2019, TreeFrog Therapeutics (France) raised USD 8.6 million in a Series A funding round for C-Stem, a 3D cell culture system used for mass-producing stem cells with short lead times while preserving genomic integrity. In June 2018, InSphero AG (Switzerland) raised USD 10 million in its latest funding round with additional financing secured from internal and external investors, which brought the total funding to date to USD 35 million. InSphero is an innovative provider of 3D cell-based platforms for drug discovery and efficacy testing. Such efforts from investors and market players are expected to offer significant growth opportunities to market players in the coming years.

CHALLENGE: Plastic waste disposal

Cell culture is a flexible research method. However, it relies heavily on plastic consumables. This has created a problem of the generation of large quantities of plastic waste every year. This has been affecting the environment adversely. Moreover, biopharmaceutical companies are increasingly adopting single-use bioprocessing systems and consumables considering the several associated advantages, such as cost reduction, faster process development time, and lower capital investments. They also reduce utilities and water costs in cleaning and sterilization, as well as batch changeover time. However, there still are serious concerns related to the disposal of solid waste materials from this alternative technology. Most single-use bioprocessing systems are made of multiple materials or layers, including polyethylene (PE), polypropylene (PP), ethylene vinyl alcohol, or nylon. Recycling is not an option for such products because they require extensive efforts to separate the components into homogeneous components. As a result, most single-use systems and their components are not suited for recycling. However, the impact of this challenge would reduce in the future as there has been a significant rise in research and innovation to create environment-friendly bioprocessing systems. For instance, the team at Nanyang Technological University (NTU) Singapore-CEA Alliance for Research in Circular Economy (SCARCE) used plastics found in electronic waste (e-waste) to reuse them as an alternative to the plastics used in laboratory cell culture containers, such as Petri dishes.

The consumables subsegment of the product segment dominated Cell Culture Market in 2020:

Based on product, the cell culture market is segmented into equipment and consumables. The cell culture equipment market is further segmented into supporting equipment, bioreactors, and storage equipment. The cell culture consumables market is segmented into sera, media & reagents, vessels, and bioreactor accessories. In 2020, the consumables segment accounted for the largest share of the market. The large share and high growth of the consumables segment can be attributed to the repeated purchase of consumables and an increase in funding for cell-based research.

Cell Culture Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for Cell Culture Market in 2020.

The global cell culture market has been segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest share of 39.6% of the cell culture market. The growing regulatory approvals for cell culture-based vaccines, technological advancements, growth in the biotechnology & pharmaceutical industries, higher investments in cell-based research, rising incidence of diseases such as cancer, and strong government support are the key factors driving the growth of the cell culture market in North America.

Key Market Players

Key players in the Cell Culture Market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD)

Segments covered

Product, Application, End user and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)

Companies covered

Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Corning Incorporated (US), Eppendorf AG (Germany), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Getinge AB (Sweden), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), HiMedia Laboratories (India), STEMCELL Technologies Inc. (Canada), Solida Biotech GmbH (Germany), Caisson Laboratories Inc. (US), PromoCell GmbH (Germany), InvivoGen (US), Pan-Biotech GmbH (Germany), Cellexus (UK), Meissner Filtration Products Inc. (US), Adolf Kόhner AG (Switzerland), SeraCare Life Sciences Inc. (US), ANGUS Chemical Company (US), and Biospherix Ltd. (US)

This report categorizes the cell culture market into the following segments and subsegments:

Cell culture Market, by Product

  • Consumables
  • Equipment

Cell culture Market, by Consumables

  • Sera, Media, and Reagents
    • Media (serum-free media, classical media & salts, stem cell culture media, specialty media, chemically defined media, and other media)
    • Sera (fetal bovine sera (FBS), adult bovine sera (ABS), and other animal sera)
    • Reagents (growth factors, supplements, buffers & chemicals, cell dissociation reagents, balanced salt solutions, attachment & matrix factors, antibiotics/antimycotics, contamination detection kits, cryoprotective agents, and other reagents)
  • Vessels
    • Roller/Roux Bottles
    • Cell Factory Systems/Cell Stacks
    • Multiwell Plates
    • Flasks
    • Petri Dishes
  • Accessories

Cell Culture Market, by Equipment

  • Supporting Equipment (filtration systems, cell counters, carbon dioxide incubators, centrifuges, autoclaves, microscopes, biosafety cabinets, and other supporting equipment such as pipetting aids, pipettes, cell inserts, cell scrapers, cell lifters, cell spreaders, pH meters, shakers, flow cytometers, and water baths)
  • Bioreactors (conventional bioreactors, single-use bioreactors)
  • Storage Equipment (Refrigerators & freezers, Cryostorage systems)

Cell culture Market, by Application

  • Biopharmaceutical Production
    • Monoclonal antibodies
    • Vaccines production
    • Other therapeutic proteins
  • Diagnostics
  • Drug Screening & Development
  • Tissue Engineering & Regenerative Medicine
    • Cell and gene therapy
    • Other tissue engineering & regenerative medicine applications
  • Other Applications

Cell culture Market, by End user

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Other End Users

Cell culture Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East and Africa (MEA)

Recent Developments

  • In October 2021, Thermo Fisher Scientific Inc. (US) launched the Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, which supports the large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells.
  • In September 2021, Cytiva expanded its manufacturing capacity for bioprocessing single-use consumables by launching 3 new manufacturing facilities in under ten months.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 67)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 73)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 3 CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2020
           FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS
           FIGURE 6 CELL CULTURE MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
           FIGURE 7 CELL CULTURE MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
    2.4 DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS
           2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
    2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 82)
    FIGURE 9 CELL CULTURE MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    FIGURE 10 CELL CULTURE MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 11 CELL CULTURE MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MARKET

4 PREMIUM INSIGHTS (Page No. - 86)
    4.1 CELL CULTURE MARKET OVERVIEW
           FIGURE 13 GROWING AWARENESS ABOUT THE BENEFITS OF CELL-BASED VACCINES AND LAUNCH OF ADVANCED CELL CULTURE PRODUCTS TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT AND COUNTRY (2020)
           FIGURE 14 CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN CELL CULTURE MARKET IN 2020
    4.3 CELL CULTURE MARKET SHARE, BY APPLICATION, 2021 VS. 2026
           FIGURE 15 BIOPHARMACEUTICAL PRODUCTION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
    4.4 CELL CULTURE MARKET SHARE, BY END USER, 2020
           FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES DOMINATED THE MARKET IN 2020
    4.5 CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH RATE FROM 2021 TO 2026

5 MARKET OVERVIEW (Page No. - 89)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 18 CELL CULTURE MARKET: DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGES
           TABLE 1 CELL CULTURE MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growing awareness about the benefits of cell-based vaccines
                               TABLE 2 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA
                    5.2.1.2 Increasing demand for monoclonal antibodies
                               TABLE 3 APPROVED MONOCLONAL ANTIBODIES FOR THERAPEUTIC USE BY US FDA (2018–2020)
                    5.2.1.3 Funding for cell-based research
                    5.2.1.4 Growing preference for single-use technologies
                               FIGURE 19 ADOPTION OF SINGLE-USE PRODUCTS IN BIOPHARMACEUTICAL MANUFACTURING, 2019
                    5.2.1.5 Launch of advanced cell culture products
                    5.2.1.6 Growing focus on personalized medicine
                               TABLE 4 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES
                               FIGURE 20 GROWING NUMBER OF FDA APPROVALS FOR PERSONALIZED MEDICINES
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of cell biology research
                    5.2.2.2 Limitations in the production of high-density cell cultures
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing demand for 3D cell culture
                    5.2.3.2 Growing risk of pandemics and communicable diseases
                    5.2.3.3 Emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Plastic waste disposal
                               TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
    5.3 RANGES/SCENARIOS
           FIGURE 21 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE CELL CULTURE MARKET
    5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE CELL CULTURE MARKET
           FIGURE 22 CELL CULTURE MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019–2021
    5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    5.6 PRICING ANALYSIS
           TABLE 6 AVERAGE SELLING PRICE OF SINGLE-USE BIOREACTORS, BY REGION (2019)
    5.7 TECHNOLOGY ANALYSIS
           TABLE 7 ADVANTAGES OF SINGLE-USE BIOREACTORS AND STAINLESS-STEEL BIOREACTORS
    5.8 PATENT ANALYSIS
           FIGURE 23 PATENT APPLICATIONS FOR THE CELL CULTURE MARKET, JANUARY 2011–DECEMBER 2021
           TABLE 8 INDICATIVE LIST OF PATENTS IN THE CELL CULTURE MARKET
    5.9 VALUE CHAIN ANALYSIS
           FIGURE 24 VALUE CHAIN ANALYSIS OF THE CELL CULTURE MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
    5.10 SUPPLY CHAIN ANALYSIS
           FIGURE 25 CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS
    5.11 ECOSYSTEM ANALYSIS OF THE CELL CULTURE MARKET
           TABLE 9 SUPPLY CHAIN ECOSYSTEM
    5.12 PORTER’S FIVE FORCES ANALYSIS
           TABLE 10 CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.12.1 THREAT OF NEW ENTRANTS
           5.12.2 THREAT OF SUBSTITUTES
           5.12.3 BARGAINING POWER OF SUPPLIERS
           5.12.4 BARGAINING POWER OF BUYERS
    5.13 REGULATORY ANALYSIS
           5.13.1 US
           5.13.2 EUROPE

6 CELL CULTURE MARKET, BY PRODUCT (Page No. - 115)
    6.1 INTRODUCTION
           TABLE 11 CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
    6.2 CONSUMABLES
           TABLE 12 CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 13 CELL CULTURE CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
           TABLE 14 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 15 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 16 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 17 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.1 SERA, MEDIA, AND REAGENTS
                    TABLE 18 SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 19 SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 20 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 21 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 22 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 23 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.2 MEDIA
                    TABLE 24 CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 25 CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 26 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 27 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 28 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 29 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.2.1 Serum-free media
                               6.2.2.1.1 Lack of sera eliminates the risk of contamination
                                            TABLE 30 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
                                            TABLE 31 SERUM-FREE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 32 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 33 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 34 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 35 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.2.2 Classical media & salts
                               6.2.2.2.1 Classical media is commonly used in virology, vaccine production, and primary tissue explant culture
                                            TABLE 36 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
                                            TABLE 37 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 38 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 39 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 40 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 41 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.2.3 Stem cell culture media
                               6.2.2.3.1 Stem cell culture media to witness the highest growth in the APAC market during the forecast period
                                            TABLE 42 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
                                            TABLE 43 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 44 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 45 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 46 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 47 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.2.4 Chemically defined (CD) media
                               6.2.2.4.1 Chemically defined media helps reduce process costs and increase product yield
                                            TABLE 48 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
                                            TABLE 49 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 50 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 51 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 52 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 53 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.2.5 Specialty media
                               6.2.2.5.1 Specialty media is suitable for the growth of selective cell types
                                            TABLE 54 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
                                            TABLE 55 SPECIALTY MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 56 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 57 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 58 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 59 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.2.6 Other media
                               TABLE 60 OTHER MEDIA OFFERED BY KEY MARKET PLAYERS
                               TABLE 61 OTHER MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 62 NORTH AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 63 EUROPE: OTHER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 64 ASIA PACIFIC: OTHER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 65 LATIN AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.3 REAGENTS
                    TABLE 66 CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 67 CELL CULTURE REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 68 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 69 EUROPE: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 70 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 71 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.1 Growth factors
                               6.2.3.1.1 Growth factors are unique cell signaling molecules that help in cell proliferation & development
                                            TABLE 72 GROWTH FACTORS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 73 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 74 EUROPE: GROWTH FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 75 ASIA PACIFIC: GROWTH FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 76 LATIN AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.2 Supplements
                               6.2.3.2.1 Supplements such as amino acids and vitamins play a key role in inducing cell growth
                                            TABLE 77 SUPPLEMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 78 NORTH AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 79 EUROPE: SUPPLEMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 80 ASIA PACIFIC: SUPPLEMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 81 LATIN AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.3 Buffers & chemicals
                               6.2.3.3.1 Chemicals and buffers are widely used in cell culture but they can be toxic at higher concentrations
                                            TABLE 82 BUFFERS & CHEMICALS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 83 NORTH AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 84 EUROPE: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 85 ASIA PACIFIC: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 86 LATIN AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.4 Cell dissociation reagents
                               6.2.3.4.1 Dissociation reagents are vital for further subculturing of cells
                                            TABLE 87 CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 88 NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 89 EUROPE: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 90 ASIA PACIFIC: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 91 LATIN AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.5 Balanced salt solutions
                               6.2.3.5.1 Balanced salt solutions are essential to maintain osmotic balance in cells
                                            TABLE 92 BALANCED SALT SOLUTIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 93 NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 94 EUROPE: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 95 ASIA PACIFIC: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 96 LATIN AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.6 Attachment & matrix factors
                               6.2.3.6.1 The development of cells is dependent on attachment factors
                                            TABLE 97 ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 98 NORTH AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 99 EUROPE: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 100 ASIA PACIFIC: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 101 LATIN AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.7 Antibiotics/antimycotics
                               6.2.3.7.1 Contamination risk makes use of antibiotics/ antimycotics essential
                                            TABLE 102 ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 103 NORTH AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 104 EUROPE: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 105 ASIA PACIFIC: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 106 LATIN AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.8 Cryoprotective reagents
                               6.2.3.8.1 Cryoprotective reagents protect tissues/cells from damage due to freezing
                                            TABLE 107 CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 108 NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 109 EUROPE: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 110 ASIA PACIFIC: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 111 LATIN AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.9 Contamination detection kits
                               6.2.3.9.1 Contamination detection kits provide rapid results
                                            TABLE 112 CONTAMINATION DETECTION KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 113 NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 114 EUROPE: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 115 ASIA PACIFIC: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 116 LATIN AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.3.10 Other reagents
                               TABLE 117 OTHER REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 118 NORTH AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 119 EUROPE: OTHER REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 120 ASIA PACIFIC: OTHER REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 121 LATIN AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.4 SERA
                    TABLE 122 SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 123 SERA MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 124 NORTH AMERICA: SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 125 EUROPE: SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 126 ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 127 LATIN AMERICA: SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.4.1 Fetal bovine sera
                               6.2.4.1.1 Use of FBS is now restricted due to regulatory guidelines
                                            TABLE 128 FETAL BOVINE SERA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 129 NORTH AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 130 EUROPE: FETAL BOVINE SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 131 ASIA PACIFIC: FETAL BOVINE SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 132 LATIN AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.4.2 Adult bovine sera
                               6.2.4.2.1 ABS is a cost-effective alternative to FBS and is used as a biochemical reagent in IVD
                                            TABLE 133 ADULT BOVINE SERA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 134 NORTH AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 135 EUROPE: ADULT BOVINE SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 136 ASIA PACIFIC: ADULT BOVINE SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 137 LATIN AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.4.3 Other animal sera
                               TABLE 138 OTHER ANIMAL SERA MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 139 NORTH AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 140 EUROPE: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 141 ASIA PACIFIC: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 142 LATIN AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.5 VESSELS
                    TABLE 143 VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 144 VESSELS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 145 NORTH AMERICA: VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 146 EUROPE: VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 147 ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 148 LATIN AMERICA: VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.5.1 Roller/roux bottles
                               6.2.5.1.1 Roller bottles offer an economical means of cultivating large cell volumes
                                            TABLE 149 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 150 NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 151 EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 152 ASIA PACIFIC: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 153 LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               6.2.5.1.2 Roller/roux bottles market, by application
                                            TABLE 154 ROLLER/ROUX BOTTLES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    6.2.5.2 Cell factory systems/cell stacks
                               6.2.5.2.1 Cell stacks require special handling equipment and skilled expertise
                                            TABLE 155 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 156 NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 157 EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 158 ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 159 LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               6.2.5.2.2 Cell factory systems/cell stacks market, by application
                                            TABLE 160 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    6.2.5.3 Multiwell plates
                               6.2.5.3.1 Multiwell plates help to run multiple tests parallelly
                                            TABLE 161 MULTIWELL PLATES MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 162 NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 163 EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 164 ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 165 LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               6.2.5.3.2 Multiwell plates market, by application
                                            TABLE 166 MULTIWELL PLATES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    6.2.5.4 Flasks
                               6.2.5.4.1 Disposable flasks are in greater demand among end users
                                            TABLE 167 FLASKS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 168 NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 169 EUROPE: FLASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 170 ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 171 LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               6.2.5.4.2 Flasks market, by application
                                            TABLE 172 FLASKS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    6.2.5.5 Petri dishes
                               6.2.5.5.1 Wide usage of Petri dishes is attributed to their ease of use
                                            TABLE 173 PETRI DISHES MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 174 NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 175 EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 176 ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 177 LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               6.2.5.5.2 Petri dishes market, by application
                                            TABLE 178 PETRI DISHES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           6.2.6 ACCESSORIES
                    TABLE 179 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 180 NORTH AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 181 EUROPE: ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 182 ASIA PACIFIC: ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 183 LATIN AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3 EQUIPMENT
           TABLE 184 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 185 CELL CULTURE EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
           TABLE 186 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 187 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 188 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 189 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.1 SUPPORTING EQUIPMENT
                    TABLE 190 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 191 CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 192 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 193 EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 194 ASIA PACIFIC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 195 LATIN AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.1.1 Filtration systems
                               6.3.1.1.1 Growing research activities in cell biology is a key factor driving market growth
                                            TABLE 196 FILTRATION SYSTEMS OFFERED BY KEY MARKET PLAYERS
                                            TABLE 197 FILTRATION SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 198 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 199 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 200 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 201 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.1.2 Cell counters
                               6.3.1.2.1 Automated cell counters are witnessing growing demand
                                            TABLE 202 CELL COUNTERS OFFERED BY KEY MARKET PLAYERS
                                            TABLE 203 CELL COUNTERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 204 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 205 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 206 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 207 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.1.3 Carbon dioxide incubators
                               6.3.1.3.1 Incubators provide control over atmospheric conditions
                                            TABLE 208 CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS
                                            TABLE 209 CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 210 NORTH AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 211 EUROPE: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 212 ASIA PACIFIC: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 213 LATIN AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.1.4 Centrifuges
                               6.3.1.4.1 Technological advances have enabled the development of faster & compact centrifuges
                                            TABLE 214 CENTRIFUGES OFFERED BY KEY MARKET PLAYERS
                                            TABLE 215 CENTRIFUGES MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 216 NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 217 EUROPE: CENTRIFUGES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 218 ASIA PACIFIC: CENTRIFUGES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 219 LATIN AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.1.5 Autoclaves
                               6.3.1.5.1 Autoclaves sterilize equipment and supplies
                                            TABLE 220 AUTOCLAVES MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 221 NORTH AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 222 EUROPE: AUTOCLAVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 223 ASIA PACIFIC: AUTOCLAVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 224 LATIN AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.1.6 Microscopes
                               6.3.1.6.1 Inverted microscopes are widely used in cell culture processes
                                            TABLE 225 MICROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 226 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 227 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 228 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 229 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.1.7 Biosafety cabinets
                               6.3.1.7.1 Cabinets are classified into three classes based on the type of protection offered
                                            TABLE 230 BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS
                                            TABLE 231 BIOSAFETY CABINETS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 232 NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 233 EUROPE: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 234 ASIA PACIFIC: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 235 LATIN AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.1.8 Other supporting equipment
                               TABLE 236 OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS
                               TABLE 237 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 238 NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 239 EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 240 ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 241 LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.2 BIOREACTORS
                    TABLE 242 BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 243 BIOREACTORS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 244 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 245 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 246 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 247 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               6.3.2.1.1 Bioreactors market, by application
                                            TABLE 248 BIOREACTORS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    6.3.2.2 Conventional bioreactors
                               6.3.2.2.1 Conventional bioreactors are widely used for large-scale bioproduction
                                            TABLE 249 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 250 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 251 EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 252 ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 253 LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.2.3 Single-use bioreactors
                               6.3.2.3.1 Convenience, ease of use, and flexibility are driving the demand for SUBs
                                            TABLE 254 SINGLE-USE BIOREACTORS OFFERED BY KEY MARKET PLAYERS
                                            TABLE 255 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 256 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 257 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 258 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 259 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.3 STORAGE EQUIPMENT
                    TABLE 260 STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 261 STORAGE EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 262 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 263 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 264 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 265 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.3.1 Refrigerators & freezers
                               6.3.3.1.1 Refrigerators & freezers are used for both short and long-term storage
                                            TABLE 266 REFRIGERATORS & FREEZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 267 NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 268 EUROPE: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 269 ASIA PACIFIC: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 270 LATIN AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.3.2 Cryostorage systems
                               6.3.3.2.1 Benefits of the long-term preservation of cell cultures are driving segment growth
                                            TABLE 271 CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                            TABLE 272 NORTH AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 273 EUROPE: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 274 ASIA PACIFIC: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                            TABLE 275 LATIN AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 CELL CULTURE MARKET, BY APPLICATION (Page No. - 224)
    7.1 INTRODUCTION
           TABLE 276 CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    7.2 BIOPHARMACEUTICAL PRODUCTION
           TABLE 277 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
           TABLE 278 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 279 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 280 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 281 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 282 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
           7.2.1 MONOCLONAL ANTIBODY PRODUCTION
                    7.2.1.1 Growing number of mAb product candidates currently in development to drive the growth of this segment
                               TABLE 283 CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 284 NORTH AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 285 EUROPE: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 286 ASIA PACIFIC: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 287 LATIN AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.2 VACCINE PRODUCTION
                    7.2.2.1 Rising incidence of infectious diseases to drive the growth of this segment
                               TABLE 288 CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 289 NORTH AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 290 EUROPE: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 291 ASIA PACIFIC: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 292 LATIN AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
                    TABLE 293 CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 294 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 295 EUROPE: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 296 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 297 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 DIAGNOSTICS
           7.3.1 INCREASING RISK OF VIRAL INFECTIONS DRIVING THE GROWTH OF THIS SEGMENT
                    TABLE 298 CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 299 NORTH AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 300 EUROPE: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 301 ASIA PACIFIC: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 302 LATIN AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.4 DRUG SCREENING & DEVELOPMENT
           7.4.1 INCREASING ADOPTION OF CELL-BASED ASSAYS IN R&D ACTIVITIES TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 303 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 304 NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 305 EUROPE: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 306 ASIA PACIFIC: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 307 LATIN AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
    7.5 TISSUE ENGINEERING & REGENERATIVE MEDICINE
           TABLE 308 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 309 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2019–2026 (USD MILLION)
           TABLE 310 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 311 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 312 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 313 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
           7.5.1 CELL & GENE THERAPY
                    7.5.1.1 Growing awareness of cell and gene therapy to drive the growth of this segment
                               TABLE 314 CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 315 NORTH AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 316 EUROPE: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 317 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 318 LATIN AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
           7.5.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
                    TABLE 319 CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 320 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 321 EUROPE: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 322 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 323 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.6 OTHER APPLICATIONS
           TABLE 324 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           TABLE 325 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 326 EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 327 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 328 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

8 CELL CULTURE MARKET, BY END USER (Page No. - 249)
    8.1 INTRODUCTION
           TABLE 329 CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
    8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           8.2.1 GROWING INVESTMENTS BY TOP MARKET PLAYERS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                    TABLE 330 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 331 NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 332 EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 333 ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 334 LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 HOSPITALS & DIAGNOSTIC LABORATORIES
           8.3.1 INCREASING APPLICATIONS OF CELL CULTURE FOR THE DIAGNOSIS OF VARIOUS DISEASES TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 335 CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 336 NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 337 EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 338 ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 339 LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.4 RESEARCH & ACADEMIC INSTITUTES
           8.4.1 INCREASING RESEARCH EFFORTS AND THE HIGH PREVALENCE OF CANCER TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                    TABLE 340 CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 341 NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 342 EUROPE: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 343 ASIA PACIFIC: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 344 LATIN AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.5 OTHER END USERS
           TABLE 345 CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
           TABLE 346 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 347 EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 348 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 349 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

9 CELL CULTURE MARKET, BY REGION (Page No. - 260)
    9.1 INTRODUCTION
           TABLE 350 CELL CULTURE MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 26 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT
           TABLE 351 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 352 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 353 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 354 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 355 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 356 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 357 NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 358 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 359 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 360 NORTH AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 361 NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 362 NORTH AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 363 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 364 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 365 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 366 NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Well-established pharmaceutical & biotechnology sector driving market growth in the US
                               TABLE 367 US: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 368 US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 369 US: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 370 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 371 US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 372 US: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 373 US: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 374 US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 375 US: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 376 US: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 377 US: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 378 US: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 379 US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 380 US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 381 US: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Advancements in the field of regenerative medicine to drive market growth in Canada
                               TABLE 382 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 383 CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 384 CANADA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 385 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 386 CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 387 CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 388 CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 389 CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 390 CANADA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 391 CANADA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 392 CANADA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 393 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 394 CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 395 CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 396 CANADA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.3 EUROPE
           TABLE 397 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 398 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 399 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 400 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 401 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 402 EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 403 EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 404 EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 405 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 406 EUROPE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 407 EUROPE: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 408 EUROPE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 409 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 410 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 411 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 412 EUROPE: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Increasing R&D investments by various key players and funding from government organizations to drive market growth
                               TABLE 413 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 414 GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 415 GERMANY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 416 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 417 GERMANY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 418 GERMANY: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 419 GERMANY: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 420 GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 421 GERMANY: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 422 GERMANY: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 423 GERMANY: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 424 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 425 GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 426 GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 427 GERMANY: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Growth in the life science industry to drive the cell culture market in the UK
                               TABLE 428 UK: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 429 UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 430 UK: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 431 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 432 UK: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 433 UK: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 434 UK: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 435 UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 436 UK: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 437 UK: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 438 UK: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 439 UK: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 440 UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 441 UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 442 UK: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Support from government and private investors to drive market growth in France
                               TABLE 443 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 444 FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 445 FRANCE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 446 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 447 FRANCE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 448 FRANCE: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 449 FRANCE: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 450 FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 451 FRANCE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 452 FRANCE: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 453 FRANCE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 454 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 455 FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 456 FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 457 FRANCE: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Italy is a leading life science research hub in Europe
                               TABLE 458 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 459 ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 460 ITALY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 461 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 462 ITALY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 463 ITALY: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 464 ITALY: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 465 ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 466 ITALY: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 467 ITALY: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 468 ITALY: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 469 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 470 ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 471 ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 472 ITALY: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increasing funding from private and public organizations to aid market growth in Spain
                               TABLE 473 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 474 SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 475 SPAIN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 476 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 477 SPAIN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 478 SPAIN: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 479 SPAIN: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 480 SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 481 SPAIN: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 482 SPAIN: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 483 SPAIN: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 484 SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 485 SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 486 SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 487 SPAIN: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 488 ROE: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 489 ROE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 490 ROE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 491 ROE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 492 ROE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 493 ROE: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 494 ROE: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 495 ROE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 496 ROE: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 497 ROE: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 498 ROE: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 499 ROE: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 500 ROE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 501 ROE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 502 ROE: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 27 ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT
           TABLE 503 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 504 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 505 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 506 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 507 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 508 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 509 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 510 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 511 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 512 ASIA PACIFIC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 513 ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 514 ASIA PACIFIC: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 515 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 516 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 517 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 518 ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 China to register the highest growth rate in the Asia Pacific cell culture market during the forecast period
                               TABLE 519 CHINA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 520 CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 521 CHINA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 522 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 523 CHINA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 524 CHINA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 525 CHINA: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 526 CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 527 CHINA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 528 CHINA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 529 CHINA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 530 CHINA: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 531 CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 532 CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 533 CHINA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Strategic developments by companies to drive the market for cell culture in Japan
                               TABLE 534 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 535 JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 536 JAPAN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 537 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 538 JAPAN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 539 JAPAN: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 540 JAPAN: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 541 JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 542 JAPAN: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 543 JAPAN: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 544 JAPAN: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 545 JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 546 JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 547 JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 548 JAPAN: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Favorable government regulations and support to drive the cell culture market in India
                               TABLE 549 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 550 INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 551 INDIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 552 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 553 INDIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 554 INDIA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 555 INDIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 556 INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 557 INDIA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 558 INDIA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 559 INDIA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 560 INDIA: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 561 INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 562 INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 563 INDIA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.4 SOUTH KOREA
                    9.4.4.1 Increasing pharmaceutical and biotech R&D investment to drive the cell culture market in South Korea
                               TABLE 564 SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 565 SOUTH KOREA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 566 SOUTH KOREA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 567 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 568 SOUTH KOREA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 569 SOUTH KOREA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 570 SOUTH KOREA: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 571 SOUTH KOREA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 572 SOUTH KOREA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 573 SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 574 SOUTH KOREA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 575 SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 576 SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 577 SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 578 SOUTH KOREA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 579 ROAPAC: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 580 ROAPAC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 581 ROAPAC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 582 ROAPAC: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 583 ROAPAC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 584 ROAPAC: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 585 ROAPAC: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 586 ROAPAC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 587 ROAPAC: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 588 ROAPAC: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 589 ROAPAC: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 590 ROAPAC: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 591 ROAPAC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 592 ROAPAC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 593 ROAPAC: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.5 LATIN AMERICA
           TABLE 594 LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 595 LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 596 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 597 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 598 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 599 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 600 LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 601 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 602 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 603 LATIN AMERICA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 604 LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 605 LATIN AMERICA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 606 LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 607 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 608 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 609 LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Increasing healthcare spending on biologics and life science research to drive market growth in Brazil
                               TABLE 610 BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 611 BRAZIL: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 612 BRAZIL: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 613 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 614 BRAZIL: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 615 BRAZIL: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 616 BRAZIL: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 617 BRAZIL: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 618 BRAZIL: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 619 BRAZIL: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 620 BRAZIL: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 621 BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 622 BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 623 BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 624 BRAZIL: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Growth in pharmaceutical manufacturing to drive R&D investments for cell culture in Mexico
                               TABLE 625 MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 626 MEXICO: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 627 MEXICO: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 628 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 629 MEXICO: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 630 MEXICO: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 631 MEXICO: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 632 MEXICO: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 633 MEXICO: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 634 MEXICO: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 635 MEXICO: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 636 MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 637 MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 638 MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 639 MEXICO: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
                    TABLE 640 ROLATAM: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 641 ROLATAM: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 642 ROLATAM: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 643 ROLATAM: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 644 ROLATAM: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 645 ROLATAM: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 646 ROLATAM: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 647 ROLATAM: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 648 ROLATAM: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 649 ROLATAM: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 650 ROLATAM: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 651 ROLATAM: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 652 ROLATAM: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 653 ROLATAM: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 654 ROLATAM: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.6 MIDDLE EAST AND AFRICA
           9.6.1 INCREASING R&D FUNDING FOR STEM CELL THERAPY DRIVING MARKET GROWTH IN MEA
                    TABLE 655 MEA: CELL CULTURE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 656 MEA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 657 MEA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 658 MEA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 659 MEA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 660 MEA: CELL CULTURE SERA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 661 MEA: CELL CULTURE VESSELS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 662 MEA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 663 MEA: CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 664 MEA: BIOREACTORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 665 MEA: CELL CULTURE STORAGE EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 666 MEA: CELL CULTURE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 667 MEA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 668 MEA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 669 MEA: CELL CULTURE MARKET, BY END USER, 2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 392)
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             FIGURE 28 KEY DEVELOPMENTS IN THE CELL CULTURE MARKET, 2019–2022
     10.3 MARKET SHARE ANALYSIS
             FIGURE 29 CELL CULTURE MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
             TABLE 670 CELL CULTURE MARKET: DEGREE OF COMPETITION
     10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
             FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE CELL CULTURE MARKET, 2018–2020
     10.5 COMPANY EVALUATION QUADRANT
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 31 CELL CULTURE MARKET: COMPANY EVALUATION QUADRANT, 2020
     10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                        FIGURE 32 CELL CULTURE MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
     10.7 PRODUCT FOOTPRINT OF COMPANIES
             TABLE 671 PRODUCT PORTFOLIO ANALYSIS: CELL CULTURE MARKET (2020)
     10.8 REGIONAL FOOTPRINT OF COMPANY
             TABLE 672 REGIONAL FOOTPRINT OF COMPANIES: CELL CULTURE MARKET (2020)
     10.9 COMPETITIVE SCENARIO
             TABLE 673 PRODUCT LAUNCHES
             TABLE 674 DEALS
             TABLE 675 EXPANSIONS

11 COMPANY PROFILES (Page No. - 403)
     11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)* 
             11.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 676 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                        FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
             11.1.2 DANAHER CORPORATION
                        TABLE 677 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.3 MERCK KGAA
                        TABLE 678 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2020)
             11.1.4 SARTORIUS AG
                        TABLE 679 SARTORIUS AG: BUSINESS OVERVIEW
                        FIGURE 36 SARTORIUS AG: COMPANY SNAPSHOT (2020)
             11.1.5 CORNING INCORPORATED
                        TABLE 680 CORNING INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 37 CORNING INCORPORATED: COMPANY SNAPSHOT (2020)
             11.1.6 EPPENDORF AG
                        TABLE 681 EPPENDORF AG: BUSINESS OVERVIEW
                        FIGURE 38 EPPENDORF AG: COMPANY SNAPSHOT (2020)
             11.1.7 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM HOLDINGS CORPORATION)
                        TABLE 682 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.8 LONZA GROUP AG
                        TABLE 683 LONZA GROUP AG: BUSINESS OVERVIEW
                        FIGURE 40 LONZA GROUP AG: COMPANY SNAPSHOT (2020)
             11.1.9 AGILENT TECHNOLOGIES, INC.
                        TABLE 684 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
             11.1.10 GETINGE AB
                        TABLE 685 GETINGE AB: BUSINESS OVERVIEW
                        FIGURE 42 GETINGE AB: COMPANY SNAPSHOT (2020)
             11.1.11 BECTON, DICKINSON AND COMPANY (BD)
                        TABLE 686 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 43 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
             11.1.12 MILTENYI BIOTEC
                        TABLE 687 MILTENYI BIOTEC: BUSINESS OVERVIEW
             11.1.13 HIMEDIA LABORATORIES
                        TABLE 688 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
             11.1.14 STEMCELL TECHNOLOGIES INC.
                        TABLE 689 STEMCELL TECHNOLOGIES, INC: BUSINESS OVERVIEW
             11.1.15 SOLIDA BIOTECH GMBH
                        TABLE 690 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats might not be captured in case of unlisted companies. 
     11.2 OTHER PLAYERS
             11.2.1 CAISSON LABORATORIES INC.
             11.2.2 PROMOCELL GMBH
             11.2.3 INVIVOGEN
             11.2.4 PAN-BIOTECH GMBH
             11.2.5 CELLEXUS
             11.2.6 MEISSNER FILTRATION PRODUCTS, INC.
             11.2.7 ADOLF KάHNER AG
             11.2.8 SERACARE LIFE SCIENCES INC.
             11.2.9 ANGUS CHEMICAL COMPANY
             11.2.10 BIOSPHERIX, LTD.

12 APPENDIX (Page No. - 482)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global cell culture market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as the World Health Organization (WHO), American Society for Cell Biology (ASCB), American Society for Gene and Cell Therapy (ASGCT), Centers of Disease Control and Prevention (CDC), International Serum Industry Association (ISIA), International Society for Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Society for In Vitro Biology (SIVB), European Society for Animal Cell Technology (ESACT), Pharmaceutical Research and Manufacturers of America (PhRMA), Department of Biotechnology (DBT), French National Research Agency, Ministry of Education, University and Research (MIUR), National Institute of Statistics (INE), Japan Agency for Medical Research and Development, Department of Regenerative Medicine and Cell and Gene Therapies, and Ministry of Health and Welfare (MoHW). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global cell culture market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global cell culture market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CDMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Cell Culture Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the cell culture market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the cell culture market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the cell culture business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Objectives

  • To define, describe, and forecast the global cell culture market based on product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall cell culture market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions; new product launches; expansions; and agreements, partnerships, and collaborations in the cell culture market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Report Code
BT 2561
Published ON
Feb, 2022
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell Culture Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved